argenx SE | ARGX - Selling And Administration Expenses

Stock Price
610.40
Daily Change
-3.40 -0.55%
Monthly
-14.05%
Yearly
8.96%
Q1 Forecast
598.33

argenx SE reported $429.62M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 4.61B 4.46B Dec/2025
Galapagos EUR 44.42M 9.87M Dec/2025
Genmab DKK 144M 18M Jun/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Qiagen NV USD 153.88M 10.77M Dec/2025
UCB EUR 1.29B 221M Dec/2024